Neutrophils are major effectors and regulators of the immune system. They play critical roles
not only in the eradication of pathogens but also in cancer initiation and progression …

Contemporary anticancer drugs have significantly improved cancer survival at the expense
of cardiovascular toxicities, including heart disease, thromboembolic disease, and …

ESC Guidelines e341 (1) the specific situation of the patient. In this respect, it is specified
that, unless otherwise provided for by national regulations, offlabel use of medication should …

Background Injectable luteinizing hormone–releasing hormone agonists (eg, leuprolide) are
the standard agents for achieving androgen deprivation for prostate cancer despite the initial …

Background Patients with cancer and cancer survivors are at increased risk for incident
heart failure, but there are conflicting data on the long-term risk for other cardiovascular …

Background More than 80% of adult patients diagnosed with cancer survive long term. Long-
term complications of cancer and its therapies may increase the risk of cardiovascular …

PURPOSE To examine cardiovascular disease (CVD) and mortality risk in women with
breast cancer (BC) by cancer therapy received relative to women without BC. METHODS …

Background: The relative cardiovascular safety of gonadotropin-releasing hormone (GnRH)
antagonists compared with GnRH agonists in men with prostate cancer and known …

Objectives: The metabolic dysfunction driven by obesity, including hyperglycemia and
dyslipidemia, increases risk for developing at least 13 cancer types. The concept of …

The development of a wide range of novel antineoplastic therapies has improved the
prognosis for patients with a wide range of malignancies, which has increased the number …